Sichuan Kelun-Biotech Biopharmaceutical Co Ltd Class H Shares 06990
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- HK$176.60
- Day Range
- HK$171.10–192.00
- 52-Week Range
- HK$62.00–195.00
- Bid/Ask
- HK$183.80 / HK$183.90
- Market Cap
- HK$40.98 Bil
- Volume/Avg
- 1.2 Mil / 513,082
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 16.75
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is an innovative biopharmaceutical company committed to the R&D, manufacturing and commercialization of novel drugs to address medical needs in China and globally. It is one of the first movers in the development of antibody-drug conjugates (ADCs), with over a decade of accumulated experience in ADC development. The company takes a systematic, indication-oriented approach to target the world’s prevalent or hard-to-treat cancers, and other diseases and conditions affecting a large and underserved population.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Large Growth
- Total Number of Employees
- 1,542
- Website
- http://www.kelun-biotech.com
Comparables
Valuation
|
Metric
|
06990
|
NYKD
|
IMU
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 11.89 | 0.88 | 3.10 |
Price/Sales | 16.75 | 22.39 | — |
Price/Cash Flow | — | — | — |
Price/Earnings
06990
NYKD
IMU
Financial Strength
|
Metric
|
06990
|
NYKD
|
IMU
|
|---|---|---|---|
Quick Ratio | 5.53 | 9.28 | 3.66 |
Current Ratio | 5.70 | 9.28 | 3.86 |
Interest Coverage | −17.47 | — | −321.34 |
Quick Ratio
06990
NYKD
IMU
Profitability
|
Metric
|
06990
|
NYKD
|
IMU
|
|---|---|---|---|
Return on Assets (Normalized) | −7.36% | −17.82% | −67.09% |
Return on Equity (Normalized) | −14.54% | −22.35% | −77.26% |
Return on Invested Capital (Normalized) | −15.82% | −25.52% | −79.58% |
Return on Assets
06990
NYKD
IMU
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Ypzbjhdx | Kkfhy | $524.5 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Hvwznwbn | Hrmqgt | $120.0 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Pmcvzsr | Llpfl | $115.9 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Wwzffqrnn | Lvzjz | $35.3 Bil | |||
| argenx SE ADR
ARGX
| Vxxjsfyl | Cwlr | $32.4 Bil | |||
| BioNTech SE ADR
BNTX
| Szdrpdcz | Bdlg | $28.2 Bil | |||
| Moderna Inc
MRNA
| Frxlkmdy | Lxcz | $25.7 Bil | |||
| United Therapeutics Corp
UTHR
| Dllsfjwx | Bxfm | $15.9 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Yjcrhkdjf | Skyhkp | $13.4 Bil | |||
| Incyte Corp
INCY
| Vfwxxxv | Xglhkv | $12.7 Bil |
United States